Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-03
2009-06-23
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07550437
ABSTRACT:
The present invention provides a composition for safely and effectively preventing and treating digestive organs diseases, particularly, gastric ulcer, duodenal ulcer, gastritis, diarrhea, enteritis and the like. There is also provided a composition having a novel mechanism of action in order to solve the problems which was difficult to be solved by the side effect previously known mechanisms of action. More particularly, there is provided a pharmaceutical composition containing an ingredient which activates PAR-2 as an essential ingredient, which is useful for inhibiting gastric acid secretion, promoting digestive tract mucus secretion, protecting digestive tract mucosa, repairing tissue of digestive organs, and preventing and treating digestive organs diseases.
REFERENCES:
patent: 5541116 (1996-07-01), Bergmann
patent: 41 32 587 (1993-05-01), None
Vergnolle et al., Proc. Natl. Acad. Sci. USA, 1998, vol. 95, pp. 7766-7771.
Abstract for JP 11 171791, Kaneka Corp (Jun. 29, 1999), Database WPI, Section Ch, Week 199963, Derwent Publications Ltd., London, GB; AN 1999-424910, XP002230573.
Corvera et al., “Thrombin and Mast Cell Tryptase Regulate Guinea-Pig Myenteric Neurons Through Proteinase-Activated Receptors-1 and -2”,Journal of Physiology, vol. 517, No. 3, pp. 741-756 (Jun. 15, 1999).
Shirai, Takayuki. “I, Juunishichou Kaiyou,” Medicina (1994), vol. 31, No. 1, pp. 30-34.
McConalogue, K. et al. “Expression and Cellular Localization of Proteinase-Activated Receptor-2 (PAR-2) in the Gastrointestinal Tract,” Gastroenterology (1997) vol. 112, No. 4 suppl., p. A1171.
Vergnolle et al., “Proteinase-Activated Receptor 2 (PAR2)-activating Peptides: Identification of a Receptor Distinct from PAR2that Regulates Intestinal Transport”,Proc. Natl. Acad. Sci. USA, vol. 95, pp. 7766-7771 (Jun. 1998).
Kawabata, Atsushi et al. “Protease Juyoutai (PAR) no Seiriteki Yakuwari: tokuni Shoukaki kei Kinou e no Kanyo ni tsuite,” Nippon Yakurigaku Zasshi (1999), vol. 114, Suppl. 1, pp. 173-179.
Araki Hiromasa
Kakehi Kazuaki
Kawabata Atsufumi
Kawai Kenzo
Kuroda Ryotaro
Browdy and Neimark , P.L.L.C.
Fuso Pharmaceutical Industries Ltd.
Teller Roy
Tsang Cecilia J.
LandOfFree
Compositions for preventing and treating digestive organs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for preventing and treating digestive organs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for preventing and treating digestive organs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4146891